AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.
Impact
One of the significant impacts of HB1956 is expected to be on the state's overall healthcare costs, as the bill aims to identify drugs that could provide substantial cost savings when imported from Canada. The bill explicitly requires a cost-benefit analysis to be included in the request to the federal government, detailing the anticipated savings and the associated costs for importation. This could potentially reshape how prescription drugs are accessed and purchased at the state level, making them more affordable for Tennesseans.
Summary
House Bill 1956 introduces amendments to various titles within the Tennessee Code Annotated, primarily focusing on the importation of prescription drugs from Canada. The bill mandates that by January 1, 2025, the Tennessee Department of Finance and Administration, in conjunction with the Department of Health and the Bureau of TennCare, must submit a request to the U.S. Secretary of Health and Human Services. This request aims to secure approval for the importation of safe and effective prescription drugs, demonstrating how these drugs would adhere to federal and state safety standards.
Conclusion
In conclusion, HB1956 reflects a growing trend among states to seek solutions for rising prescription drug costs. By allowing for the importation of certain medications from Canada, the bill aims to empower both policymakers and the healthcare system to explore alternatives that could enhance affordability while ensuring compliance with health standards. The potential repercussions of this bill will likely be examined closely by various stakeholders as it progresses through the legislative process.
Contention
Notably, the bill may face contention surrounding the regulatory implications of importing drugs from another country. Critics may express concerns about the safety and efficacy of drugs that are imported, as well as questions regarding compliance with U.S. pharmaceutical laws. The requirement to list potential suppliers and ensure their adherence to relevant laws adds another layer of complexity and accountability, which may be debated during discussions on the bill.
Crossfiled
AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 49; Title 53; Title 55; Title 56; Title 63; Title 68 and Title 71, relative to healthcare professions.